Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates In Congestive HEart Failure (NICE) Study

Cardiology

Volumn 91, Issue 1, 1999, Pages 1-7

  Lewis, Basil S ^a   Rabinowitz, Babeth ^a   Schlesinger, Zwi ^a   Caspi, Abraham ^a   Markiewicz, Walter ^a   Rosenfeld, Tiberio ^a   Sclarovsky, Samuel ^a   Ermer, Wolfgang ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Exercise performance; Heart failure; Nitrates; Pharmacotherapy

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; FUROSEMIDE; ISOSORBIDE 5 NITRATE; NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; HEADACHE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE VOLUME; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE;

ADMINISTRATION, ORAL; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; DIURETICS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; QUALITY OF LIFE; VASODILATOR AGENTS;

EID: 0033039351     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006870     Document Type: Article

References (41)

1. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT). N Engl J Med 1986;314:1547-1552.
2. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson PA, Cintron G, Shabetai R, Haakenson C: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
3. Ziesche S, Cobb FR, Cohn JN, Johnson G, Tristani F: Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 suppl):V156-V164.
4. Elkayam U: Nitrates in the treatment of congestive heart failure. Am J Cardiol 1996;77: 41C-51C.
5. Keck M: Sustained-release isosorbide-5-mononitrate supports captopril treatment of heart failure due to coronary artery disease. A pilot study. Clin Drug Invest 1997;14:294-300.
6. Rabinowitz B, Hod H, Elazar E, Klein R, Neufeld H: Hemodynamics, circulating catecholamines and response to intravenous nitrate therapy in a specific subset of acute myocardial infarctions. Cardiology 1988;75:260-268.
7. Arad M, Elazar E, Shotan A, Klein R, Rabinowitz B: Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Cardiology 1996;87:12-17.
8. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R: A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-683.
9. Poole-Wilson PA: The origin of symptoms on patients with chronic heart failure. Eur Heart J 1988;9(suppl H):49-53.
10. Meiler SE, Ashton JJ, Moeschberger ML, Unverferth DV, Leier CV: An analysis of the determinants of exercise performance in congestive heart failure. Am Heart J 1987;113: 1207-1217.
11. Volterrani M, Clark AL, Ludman PF, Swan JW, Adamopoulos S, Piepoli M, Coats AJ: Predictors of exercise capacity in chronic heart failure. Eur Heart J 1994; 15:801-809.
12. Franciosa JA, Park M, Levine TB: Lack of correlation between exercise capacity and indices of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-39.
13. Weber KT, Wilson JR, Janicki J, Lickoff MJ: Exercise testing in the evaluation of the patient with chronic heart failure. Am Rev Respir Dis 1984;129(suppl):60-62.
14. Harrington D, Coats AJS: Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure. Eur Heart J 1997;18:1865-1872.
15. 31P nuclear magnetic resonance spectroscopy in severe congestive heart failure. Am J Cardiol 1995;76:606-609.
16. Minotti JR, Christoph I, Weiner MW, Wells L, Massie BM: Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest 1991;88:2077-2082.
17. Naveri HK, Leinonen H, Kiilavuori K, Harkonen M: Skeletal muscle lactate accumulation and creatine phosphate depletion during heavy exercise in congestive heart failure. Eur Heart J 1997;18:1937-1945.
18. Bassenge E, Fink B, Skatchkov M, Dikalov S: Endothelium and platelet activity in heart failure. J Card Fail 1996;2:S203-S208.
19. Mann DL: The effect of tumor necrosis factor-alpha on cardiac structure and function: A tale of two cytokines. J Card Fail 1996;2:S165-S172.
20. Yokoyama M, Hirata K, Kawashima S, Kawahara Y: Regulation of nitric acid synthase gene expression by cytokines. J Card Fail 1996;2: S179-S185.
21. Williams DO, Amsterdam EA, Mason DT: Hemodynamic effects of nitroglycerin in acute myocardial infarction. Decrease in ventricular preload at the expense of cardiac output. Circulation 1975;51:421-427.
22. Rabinowitz B, Tamari I, Elazar E, Neufeld HN: Intravenous isosorbide dinitrate in patients with refractory pump failure and acute myocardial infarction. Circulation 1982;65: 771-778.
23. Packer M: New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure. Am J Med 1983; 74(suppl):61-72.
24. Roth A, Weber L, Freidenberger L, Rahimtoola SH, Elkayam U: Hemodynamic effects of intravenous isosorbide dinitrate and nitroglycerin in acute myocardial infarction and elevated pulmonary artery wedge pressure. Chest 1987;91:190-196.
25. Rabinowitz B, Katz A, Shotan A, Chouraqui P, Neufeld H: Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology. Eur Heart J 1988;9(suppl A): 175-180.
26. Lewis BS, Hardoff R, Halon DA: Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: Relation to initial hemodynamics and the preload reserve mechanism. Clin Cardiol 1989;12:514-520.
27. Torfgard KE, Ahlner J: Mechanism of action of nitrates. Cardiovasc Drugs Ther 1994;8:701-717.
28. Levine TB, Levine AB, Keteyian SJ, Narins B, Lesch M: Reverse remodeling in heart failure with intensification of vasodilator therapy. Clin Cardiol 1997;20:697-702.
29. Kubo SH, Rector TS, Bank AJ: Endothelial nitric oxide pathway function in the peripheral vasculature of patients with heart failure. J Card Fail 1996;2:S217-S223.
30. Takeshita A, Hirooka Y, Imaizumi T: Role of endothelium in control of forearm blood flow in patients with heart failure. J Card Fail 1996; 2:S209-S215.
31. Munzel T, Kurz S, Drexler H: Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE inhibitors? Herz 1993;18(suppl 1): 400-405.
32. Schaufelberger M, Andersson G, Eriksson BO, Grimby G, Held P, Swedberg K: Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril. Eur Heart J 1996;17:1678-1685.
33. Wieshammer S, Hetzel M, Hetzel J, Kochs M, Hombach V: Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated by captopril. Br Heart J 1993;70: 17-21.
34. Verma SP, Silke B, Nelson GIC: Hemodynamics advantages of a combined inotropic-venodilator regimen over inotropic monotherapy in acute heart failure. J Cardiol Pharmacol 1985; 7:943-947.
35. Halon DA, Rosenfeld T, Hardoff R, Lewis BS: Advantage of combined therapy with captopril and nitrates in severe congestive heart failure. Isr J Med Sci 1988;24:664-670.
36. Mehra A, Ostrzega E, Shotan A, Johnson JV, Elkayam U: Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril. Am J Cardiol 1992;70:1310-1314.
37. Halon DA, Rosenfeld T, Hardoff R, Lewis BS: The benefit of combined therapy with captopril and nitrates in severe congestive heart failure. Cardiology 1994;84(suppl 1):43-51.
38. Thadani U: Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther 1997;10:735-742.
39. Bauer JA, Fung HL: Concurrent hydralazine administration prevents nitroglycerin-induced tolerance in experimental heart failure. Circulation 1991;84:35-39.
40. Gogia H, Mehra A, Parikh S, Raman M, Ajit-Uppal J, Johnson J, Elkayam U: Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol 1995;26:1575-1580.
41. Munzel T, Bassenge E: Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation 1996;93: 2052-2058.